These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

478 related articles for article (PubMed ID: 35163380)

  • 21. The emerging roles of tumor-derived exosomes in hematological malignancies.
    Boyiadzis M; Whiteside TL
    Leukemia; 2017 Jun; 31(6):1259-1268. PubMed ID: 28321122
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune Suppressive Effects of Plasma-Derived Exosome Populations in Head and Neck Cancer.
    Beccard IJ; Hofmann L; Schroeder JC; Ludwig S; Laban S; Brunner C; Lotfi R; Hoffmann TK; Jackson EK; Schuler PJ; Theodoraki MN
    Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32708274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exosomes in Cancer Disease.
    Zöller M
    Methods Mol Biol; 2016; 1381():111-49. PubMed ID: 26667458
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges in Exosome Isolation and Analysis in Health and Disease.
    Ludwig N; Whiteside TL; Reichert TE
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546622
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human tumor-derived exosomes (TEX) regulate Treg functions via cell surface signaling rather than uptake mechanisms.
    Muller L; Simms P; Hong CS; Nishimura MI; Jackson EK; Watkins SC; Whiteside TL
    Oncoimmunology; 2017; 6(8):e1261243. PubMed ID: 28919985
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluating tumor cell- and T cell-derived extracellular vesicles as potential biomarkers of cancer and immune cell competence.
    Whiteside TL
    Expert Rev Mol Diagn; 2023 Feb; 23(2):109-122. PubMed ID: 36787282
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Isolation and Analysis of Tumor-Derived Exosomes.
    Ludwig N; Hong CS; Ludwig S; Azambuja JH; Sharma P; Theodoraki MN; Whiteside TL
    Curr Protoc Immunol; 2019 Dec; 127(1):e91. PubMed ID: 31763776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Exo-miRNAs in Cancer: A Focus on Therapeutic and Diagnostic Applications.
    Ingenito F; Roscigno G; Affinito A; Nuzzo S; Scognamiglio I; Quintavalle C; Condorelli G
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31546654
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-Associated Exosomes: A Potential Therapeutic Target for Restoring Anti-Tumor T Cell Responses in Human Tumor Microenvironments.
    Shenoy GN; Bhatta M; Bankert RB
    Cells; 2021 Nov; 10(11):. PubMed ID: 34831378
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma-released exosomes directly activate the mitochondrial apoptotic pathway of CD4
    Zhou J; Yang Y; Wang W; Zhang Y; Chen Z; Hao C; Zhang J
    Exp Cell Res; 2018 Oct; 371(2):364-371. PubMed ID: 30149000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The cancer exosomes: Clinical implications, applications and challenges.
    Tang Z; Li D; Hou S; Zhu X
    Int J Cancer; 2020 Jun; 146(11):2946-2959. PubMed ID: 31671207
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor-Derived Exosomes Mediate the Instability of Cadherins and Promote Tumor Progression.
    Wang B; Tan Z; Guan F
    Int J Mol Sci; 2019 Jul; 20(15):. PubMed ID: 31357383
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cancer-derived exosomic microRNAs shape the immune system within the tumor microenvironment: State of the art.
    Fanini F; Fabbri M
    Semin Cell Dev Biol; 2017 Jul; 67():23-28. PubMed ID: 27956165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosome-Mediated Immunosuppression in Tumor Microenvironments.
    Xie QH; Zheng JQ; Ding JY; Wu YF; Liu L; Yu ZL; Chen G
    Cells; 2022 Jun; 11(12):. PubMed ID: 35741075
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Double Face of Exosome-Carried MicroRNAs in Cancer Immunomodulation.
    Alfonsi R; Grassi L; Signore M; Bonci D
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29652798
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxia Induced Changes of Exosome Cargo and Subsequent Biological Effects.
    Jiang H; Zhao H; Zhang M; He Y; Li X; Xu Y; Liu X
    Front Immunol; 2022; 13():824188. PubMed ID: 35444652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exo-MFA - A 13C metabolic flux analysis framework to dissect tumor microenvironment-secreted exosome contributions towards cancer cell metabolism.
    Achreja A; Zhao H; Yang L; Yun TH; Marini J; Nagrath D
    Metab Eng; 2017 Sep; 43(Pt B):156-172. PubMed ID: 28087332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered Tumor-Derived Extracellular Vesicles: Potentials in Cancer Immunotherapy.
    Taghikhani A; Farzaneh F; Sharifzad F; Mardpour S; Ebrahimi M; Hassan ZM
    Front Immunol; 2020; 11():221. PubMed ID: 32210954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging role of exosomes and exosomal microRNA in cancer: pathophysiology and clinical potential.
    Elewaily MI; Elsergany AR
    J Cancer Res Clin Oncol; 2021 Mar; 147(3):637-648. PubMed ID: 33511427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The function and clinical application of extracellular vesicles in innate immune regulation.
    Zhou X; Xie F; Wang L; Zhang L; Zhang S; Fang M; Zhou F
    Cell Mol Immunol; 2020 Apr; 17(4):323-334. PubMed ID: 32203193
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.